Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00567294 · ClinicalTrials.gov registry record · Phase 3
Evaluating Ways to Improve Medication Use Among People With Osteoporosis
A Phase 3 study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,087
- Enrollment target
NCT00567294 is a Phase 3 study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 2,087 participants.
The verdict
NCT00567294, a Phase 3 study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,087 participants
- Enrollment target
Study Summary
Osteoporosis is a common bone disease in older adults in which the bones become weaker and prone to fracture. Medications are available to slow or even stop disease progression. However, very few adults who are prescribed osteoporosis medications actually follow through with filling their prescriptions and taking the medications. Ways to improve medication use have not been well developed or adequately tested. The purpose of this study is to evaluate a telephone coaching program, with or without helpful adherence notifications to doctors, in improving treatment adherence in older adults who are starting an osteoporosis medication.
Interventions
- BEHAVIORAL Mailed education
- BEHAVIORAL Telephone coaching program for patients
- BEHAVIORAL Medication adherence alert program for doctors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,087 participants |
| Start Date | 2007-11 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00567294
The ClinicalTrials.gov registry entry for NCT00567294 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,087 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Mailed education is the first listed.
NCT00567294 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00567294 about?
NCT00567294 is a clinical study titled "Evaluating Ways to Improve Medication Use Among People With Osteoporosis". Osteoporosis is a common bone disease in older adults in which the bones become weaker and prone to fracture. Medications are available to slow or even stop disease progression. However, very few adults who are prescribed osteoporosis medications actually follow through with filling their prescripti...
What is the current status of trial NCT00567294?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,087 participants. The study started on 2007-11. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00567294?
The interventions under investigation include: Mailed education (BEHAVIORAL), Telephone coaching program for patients (BEHAVIORAL), Medication adherence alert program for doctors (BEHAVIORAL).
Who is sponsoring clinical trial NCT00567294?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.